Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EBITDA: 2009-2011

Historic EBITDA for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$33.3 million.

  • Lexicon Pharmaceuticals' EBITDA fell 48.68% to -$33.3 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$114.1 million, marking a year-over-year decrease of 19.20%. This contributed to the annual value of -$114.1 million for FY2011, which is 19.20% down from last year.
  • Lexicon Pharmaceuticals' EBITDA amounted to -$33.3 million in Q4 2011, which was down 29.78% from -$25.7 million recorded in Q3 2011.
  • Lexicon Pharmaceuticals' 5-year EBITDA high stood at -$21.8 million for Q3 2009, and its period low was -$33.3 million during Q4 2011.
  • Its 3-year average for EBITDA is -$25.3 million, with a median of -$24.3 million in 2010.
  • Per our database at Business Quant, Lexicon Pharmaceuticals' EBITDA rose by 1.57% in 2010 and then crashed by 48.68% in 2011.
  • Quarterly analysis of 3 years shows Lexicon Pharmaceuticals' EBITDA stood at -$22.8 million in 2009, then increased by 1.57% to -$22.4 million in 2010, then slumped by 48.68% to -$33.3 million in 2011.
  • Its EBITDA was -$33.3 million in Q4 2011, compared to -$25.7 million in Q3 2011 and -$25.9 million in Q2 2011.